Pharmacy alerts
-
Rasburicase for tumour lysis syndrome, alert on harm from delayed administration
National Patient Safety Alert: NHS England has published a National Patient Safety Alert on harm from delayed administration of rasburicase for tumour lysis syndrome.
-
Hikma Farmacêutica, Gemcitabine 2g/52.6ml concentrate for solution for infusion defect
Class 4 medicines defect notification: The MHRA has published a Class 4 medicines defect notification for Gemcitabine 2g/52.6ml concentrate for solution for infusion.
-
Magnesium Glycinate Gummies, advice to stop all use
The MHRA has advised parents and caregivers to stop all use of Nutrition Ignition Kids Magnesium Glycinate Gummies due to the presence of undeclared melatonin.
-
Antimicrobial agents used in tuberculosis treatment shortage
National Patient Safety Alert: The DHSC has published a National Patient Safety Alert on a shortage of antimicrobial agents used in tuberculosis (TB) treatment.
-
Bumetanide 1mg tablets, update on shortage
National Patient Safety Alert: The MHRA has published on its National Patient Safety Alert on the shortage of Bumetanide 1mg tablets.
-
Bumetanide 1mg tablets shortage
National Patient Safety Alert: The MHRA has published a National Patient Safety Alert on the shortage of bumetanide 1mg tablets.